Abstract
OBJECTIVE
The goal of treatment is a plantigrade, stable, ulcer-free foot which can be addressed with diabetes-adapted insoles and/or DNOAP shoes.
INDICATIONS
Charcot foot of the midfoot with/without infection-free ulcers.
CONTRAINDICATIONS
Inacceptable anesthesiological risk in polymorbidity. Severe anesthesiological risks in multimorbid patients; symptomatic peripheral arterial occlusive disease not suitable for reconstruction; infections PEDIS/IWGDF grade 3 or 4, nonreconstructable osseous defects.
SURGICAL TECHNIQUE
Corrective arthrodesis with segmental resection or bone grafting of the midfoot to achieve a plantigrade foot position. Plantar plate application or intramedullary (e.g., midfoot fusion bolt) and extramedullary (preferably: angular stable locking plates) implant combinations to create the highest possible degree of primary stability of the medial and/or lateral foot columns (superconstruct). In case of higher degrees of instability, the hindfoot should also be included into the arthrodesis.
POSTOPERATIVE MANAGEMENT
Partial weight-bearing (20 kg) with forearm crutches for 3-5 months postoperatively in special orthosis or total contact cast. Therapeutic shoes with diabetes-adapted insoles with full weight-bearing.
RESULTS
Using any of these stabilization variants, a plantigrade, stable, and long-lasting ulcer-free foot may be obtained that is suitable for custom-made footwear. The outcome does not depend on definite osseous healing of the arthrodesis and allows for the patient to have a self-determined lifestyle. The consecutive rate of amputation is low.
COMPLICATIONS
High rate of surgical complications (e.g., infection, implant failure, non-union, loss of correction, reulceration), in particular, in cases of inadequate indication or insufficient primary stability.
TY - JOUR
T1 - [Corrective arthrodesis of midfoot Charcot neuroosteoarthropathy with internal fixation].
AU - Mittlmeier,T,
AU - Eschler,A,
Y1 - 2015/04/10/
PY - 2014/12/19/received
PY - 2015/02/22/accepted
PY - 2015/02/09/revised
PY - 2015/4/12/entrez
PY - 2015/4/12/pubmed
PY - 2016/11/9/medline
SP - 139
EP - 53
JF - Operative Orthopadie und Traumatologie
JO - Oper Orthop Traumatol
VL - 27
IS - 2
N2 - OBJECTIVE: The goal of treatment is a plantigrade, stable, ulcer-free foot which can be addressed with diabetes-adapted insoles and/or DNOAP shoes. INDICATIONS: Charcot foot of the midfoot with/without infection-free ulcers. CONTRAINDICATIONS: Inacceptable anesthesiological risk in polymorbidity. Severe anesthesiological risks in multimorbid patients; symptomatic peripheral arterial occlusive disease not suitable for reconstruction; infections PEDIS/IWGDF grade 3 or 4, nonreconstructable osseous defects. SURGICAL TECHNIQUE: Corrective arthrodesis with segmental resection or bone grafting of the midfoot to achieve a plantigrade foot position. Plantar plate application or intramedullary (e.g., midfoot fusion bolt) and extramedullary (preferably: angular stable locking plates) implant combinations to create the highest possible degree of primary stability of the medial and/or lateral foot columns (superconstruct). In case of higher degrees of instability, the hindfoot should also be included into the arthrodesis. POSTOPERATIVE MANAGEMENT: Partial weight-bearing (20 kg) with forearm crutches for 3-5 months postoperatively in special orthosis or total contact cast. Therapeutic shoes with diabetes-adapted insoles with full weight-bearing. RESULTS: Using any of these stabilization variants, a plantigrade, stable, and long-lasting ulcer-free foot may be obtained that is suitable for custom-made footwear. The outcome does not depend on definite osseous healing of the arthrodesis and allows for the patient to have a self-determined lifestyle. The consecutive rate of amputation is low. COMPLICATIONS: High rate of surgical complications (e.g., infection, implant failure, non-union, loss of correction, reulceration), in particular, in cases of inadequate indication or insufficient primary stability.
SN - 1439-0981
UR - https://www.unboundmedicine.com/medline/citation/25862129/[Corrective_arthrodesis_of_midfoot_Charcot_neuroosteoarthropathy_with_internal_fixation]_
L2 - https://doi.org/10.1007/s00064-014-0338-8
DB - PRIME
DP - Unbound Medicine
ER -